Signoret-Bravo MT, Michel-Izeta BE

Language: Spanish
References: 4
Page: 299-301
PDF size: 633.42 Kb.

ABSTRACT

Stevens–Johnson syndrome was first described in 1922 by Drs. Stevens and Johnson. We propose that the original cases were in fact manifestations of Mycoplasma pneumoniae– induced rash and mucositis (MIRM), a distinct clinical entity recognized as distinct nearly a century later. This article reflects on the evolution of clinical knowledge, the limitations of eponyms, and the enduring value of case reports in the construction of medical knowledge.

REFERENCES

1. Stevens AM, Johnson FC. A new eruptive fever associatedwith stomatitis and ophthalmia: report of two cases in children.Am J Dis Child. 1922;24(6):526-533. Disponible en: https://doi.org/10.1001/archpedi.1922.04120120077005

2. Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, analgorithm for assessment of drug causality in Stevens-Johnsonsyndrome and toxic epidermal necrolysis: comparison withcase-control analysis. Clin Pharmacol Ther. 2010;88(1):60-68.Disponible en: https://doi.org/10.1038/clpt.2009.252

3. Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasmapneumoniae-induced rash and mucositis as a syndrome distinctfrom Stevens-Johnson syndrome and erythema multiforme: asystematic review. J Am Acad Dermatol. 2015;72(2):239-245.Disponible en: https://doi.org/10.1016/j.jaad.2014.06.026

4. Chen N, Li M. Case report and literature review: clinicalcharacteristics of 10 children with Mycoplasma pneumoniaeinducedrash and mucositis. Front Pediatr. 2022;10:823376.Disponible en: https://doi.org/10.3389/fped.2022.823376